These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
678 related items for PubMed ID: 28270111
1. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity. Barabas S, Spindler T, Kiener R, Tonar C, Lugner T, Batzilla J, Bendfeldt H, Rascle A, Asbach B, Wagner R, Deml L. BMC Immunol; 2017 Mar 07; 18(1):14. PubMed ID: 28270111 [Abstract] [Full Text] [Related]
2. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients. Banas B, Böger CA, Lückhoff G, Krüger B, Barabas S, Batzilla J, Schemmerer M, Köstler J, Bendfeldt H, Rascle A, Wagner R, Deml L, Leicht J, Krämer BK. BMC Immunol; 2017 Mar 07; 18(1):15. PubMed ID: 28270092 [Abstract] [Full Text] [Related]
9. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P. Transpl Immunol; 2009 Mar 07; 20(4):238-42. PubMed ID: 19032982 [Abstract] [Full Text] [Related]
11. Rapid generation of CMV pp65-specific T cells for immunotherapy. Bao L, Sun Q, Lucas KG. J Immunother; 2007 Mar 07; 30(5):557-61. PubMed ID: 17589296 [Abstract] [Full Text] [Related]
12. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B. J Immunol Methods; 2014 Jun 07; 408():101-13. PubMed ID: 24877879 [Abstract] [Full Text] [Related]
13. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant. López-Oliva MO, Martinez V, Buitrago A, Jiménez C, Rivas B, Escuin F, Santana MJ, Selgas R, Bellón T. Transplantation; 2014 Apr 27; 97(8):839-45. PubMed ID: 24345896 [Abstract] [Full Text] [Related]
14. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients. Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Bravo D, Clari MÁ, Navarro D. J Med Virol; 2012 Feb 27; 84(2):259-67. PubMed ID: 22170546 [Abstract] [Full Text] [Related]
15. Functional impairment of CMV-reactive cellular immunity during pregnancy. Reuschel E, Barabas S, Zeman F, Bendfeldt H, Rascle A, Deml L, Seelbach-Goebel B. J Med Virol; 2017 Feb 27; 89(2):324-331. PubMed ID: 27447923 [Abstract] [Full Text] [Related]
17. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. Gibson L, Piccinini G, Lilleri D, Revello MG, Wang Z, Markel S, Diamond DJ, Luzuriaga K. J Immunol; 2004 Feb 15; 172(4):2256-64. PubMed ID: 14764694 [Abstract] [Full Text] [Related]
18. T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control. Popescu I, Pipeling MR, Shah PD, Orens JB, McDyer JF. J Immunol; 2014 Dec 01; 193(11):5709-5722. PubMed ID: 25339676 [Abstract] [Full Text] [Related]
19. CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. Slezak SL, Bettinotti M, Selleri S, Adams S, Marincola FM, Stroncek DF. J Transl Med; 2007 Mar 28; 5():17. PubMed ID: 17391521 [Abstract] [Full Text] [Related]
20. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells. Abu-Khader A, Krause S. Eur J Haematol; 2013 Dec 28; 91(6):534-45. PubMed ID: 23952609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]